|
KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
1.70%
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
1.69%
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
1.69%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
1.68%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
1.68%
|
US
|
NASDAQ
|
|
MYOV
|
Myovant Sciences Ltd.
|
1.68%
|
US
|
NYSE
|
|
GILD
|
Gilead Sciences, Inc.
|
1.68%
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
1.67%
|
US
|
NASDAQ
|
|
ADMA
|
ADMA Biologics Inc
|
1.67%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
1.66%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
1.65%
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
1.65%
|
US
|
NASDAQ
|
|
SAGE
|
Sage Therapeutics, Inc.
|
1.64%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
1.63%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
1.63%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
1.63%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
1.62%
|
US
|
NASDAQ
|
|
LEGN
|
Legend Biotech Corporation
|
1.61%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
1.60%
|
US
|
NASDAQ
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
1.59%
|
US
|
NASDAQ
|